Phathom Pharmaceuticals Inc - fluxo de caixa trimestral (NASDAQ:PHAT) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -63.46 M-84.93 M-62.73 M-14.12 M-5 M -166.78 M Cash from investing activities -5 000-18 K-97 K-27 K-87 K -229 K Cash from financing activities 26.05 M080 K-271 K-97 K -288 K Free cash flow -63.46 M-84.95 M-62.83 M-14.14 M-5.09 M -167 M

Notícias

Rocket Pharmaceuticals e Argan sobem no pré-mercado; Two Harbors recua

Barclays eleva rating da Phathom Pharmaceuticals com base em perspectivas de receita

Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug

Guggenheim eleva preço-alvo das ações da Phathom para US$ 25 após superar receita

Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript

Stifel reitera recomendação de compra para Phathom com preço-alvo de US$ 28